Skip to content
Review

Lipid metabolism in moyamoya disease: Emerging evidence, vascular remodeling, and therapeutic implications

Sep 2026 · Neurological Sciences · Vol 47 · 0 citations · 63 references
Medicine

TL;DR

Evidence on lipid metabolic abnormalities in MMD is summarized, including clinical associations, lipid-related markers, multi-omics findings, potential mechanisms, and therapeutic implications of lipid-modulating approaches.

View source

Similar papers

Meta-analysis Open access Aug 2026

Changes in vascular structure and function in primary hyperparathyroidism: a systematic review and meta-analysis

Introduction Cardiovascular (CV) diseases, particularly ischemic heart disease and stroke, remain the leading cause of mortality worldwide and constitute a major global health challenge. Primary hyperparathyroidism (PHPT), a prevalent endocrine disorder, has recently emerged as a potential contributor to CV risk, altho...

Ana Gheorghe-Milea, C. E. Georgescu · 0 citations
Review Open access Sep 2026

Statins and Myasthenia Gravis: Clinical Implications and Pathogenesis

Statins are widely prescribed lipid-lowering agents and remain central to the prevention of atherosclerotic cardiovascular disease. Although generally well tolerated, they have been associated with neuromuscular adverse events, including new-onset or worsening myasthenia gravis (MG). Current evidence supports a primari...

Xiao Tian, Pei-Xiang Zhang · 0 citations
Review Open access 2026

Clinical significance and management of hypertriglyceridemia

It is concluded that secondary causes must be ruled out upon diagnosis and non-HDL cholesterol is highlighted as a critical secondary therapeutic target for comprehensive cardiovascular risk management.

L. Popović, Sandra Singh-Lukač, I. Rasulić et al. · 0 citations
Review Sep 2026

Atherosclerosis as a Neuroimmune and Neurovascular Disorder: Pharmacological Opportunities Beyond Lipid Lowering.

INTRODUCTION/OBJECTIVE Atherosclerosis is traditionally defined as a lipid-driven inflammatory disease of medium and large arteries, but vascular inflammation also interacts with immune, autonomic, metabolic, and brain vascular pathways. This narrative review synthesizes evidence supporting an artery-immune-brain frame...

F. Epelde · 0 citations
Review Aug 2026

Polycystic Ovary Syndrome and Cardiovascular Risk: Mechanisms, Clinical Evidence, and Prevention Strategies.

This focused narrative review synthesizes contemporary evidence on the mechanistic, subclinical, and clinical links between PCOS and cardiovascular disease and examines how hyperandrogenism may contribute to insulin resistance and related abnormalities, including dyslipidemia, hypertension, metabolic dysfunction-associ...

M. Moore, R. Hirani, Samy Khessib et al. · 0 citations
Open access Sep 2026

Lipid-Related Metabolic Dysregulation Affects Survival in Idiopathic Normal Pressure Hydrocephalus.

BACKGROUND Idiopathic normal pressure hydrocephalus (iNPH) is associated with increased mortality and vascular-metabolic comorbidity, but prognostic biomarkers are lacking. OBJECTIVES To assess the triglycerides/high-density lipoprotein cholesterol (TG/HDL-C) ratio, an insulin resistance (IR) marker, and its associat...

Jacopo Bissacco, D. Mascioli, C. Simonetta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.